In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Our cells harbor a DNA detector termed cGAS to inform the immune system of viral and bacterial infections, cell death, as ...